While there are myriad genetic, environmental, and epigenetic risk factors for schizophrenia, there is broad consensus that abnormal glutamate neurotransmission has a role in the ultimate clinical manifestations of this devastating illness. The glutamate hypothesis has evolved beyond the simplistic notion of NMDA receptor dysfunction, based in part on the dearth of consistently reproducible findings for altered NMDA receptor and binding site expression in postmortem studies. In this review, we review cortical glutamate receptor expression in this illness, and highlight postmortem data from novel families of glutamate receptor interacting proteins. We also discuss the vesicular and plasma membrane glutamate transporters, and review studies that have examined cortical glutamate transporter expression in this illness. Finally, we discuss the hypothesis that trafficking, assembly of signaling complexes, and receptor recycling might be dysregulated and represent important new targets for pharmacological manipulation in the treatment of schizophrenia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Bauer, D., McCullumsmith, R.E., Meador-Woodruff, J.H. (2008). A Role for Glutamate Receptors, Transporters, and Interacting Proteins in Cortical Dysfunction in Schizophrenia. In: O'Donnell, P. (eds) Cortical Deficits In Schizophrenia. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-74351-6_6
Download citation
DOI: https://doi.org/10.1007/978-0-387-74351-6_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-74350-9
Online ISBN: 978-0-387-74351-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)